Sucralfate
Rank #258 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$48.5M
Total Cost
689,007
Total Claims
$48.5M
Total Cost
22,924
Prescribers
$70
Cost per Claim
147,545
Beneficiaries
906,110
30-Day Fills
$2,115
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$48.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $48.5M total
Top Prescribers of Sucralfate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jiho Choi | Family Practice | Annandale, VA | 264 | $90K |
| 2 | Federico Gregory-Gonzalez | Gastroenterology | Guaynabo, PR | 556 | $89K |
| 3 | Jaesoo Pak | Internal Medicine | Cerritos, CA | 529 | $85K |
| 4 | Don Heacock | Gastroenterology | Macon, GA | 297 | $83K |
| 5 | Rubayat Rahman | Gastroenterology | Davenport, FL | 493 | $80K |
| 6 | Menelito Lilagan | Gastroenterology | Saginaw, MI | 497 | $62K |
| 7 | Jose Munoz Acaba | Gastroenterology | San Juan, PR | 375 | $60K |
| 8 | Juan Marques-Lespier | Gastroenterology | Manati, PR | 394 | $60K |
| 9 | Dale Pappas | Physician Assistant | Springfield, MA | 214 | $56K |
| 10 | Ramon Marrero | Gastroenterology | Bayamon, PR | 285 | $52K |
| 11 | Michael Satchell | Family Practice | Albany, GA | 511 | $50K |
| 12 | Virgen Baez Hernandez | Gastroenterology | Caguas, PR | 405 | $50K |
| 13 | Bahram Ahmadi | Gastroenterology | Sebring, FL | 701 | $47K |
| 14 | Michael Raines | Family Practice | Americus, GA | 406 | $39K |
| 15 | Donald Vollmer | Family Practice | Hendersonville, TN | 898 | $38K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
| 260 | Cabotegravir/Rilpivirine (Cabenuva) | $48.1M | 7,384 |
| 261 | Cenobamate (Xcopri) | $47.6M | 33,831 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology